Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin

Completed

Conditions studied: Skin Cancer

In brief

The goal of this research program is to develop a simple, noninvasive diagnostic device for assessing skin pathology without the need for a biopsy. The device being studied is a single system capable of collecting three spectroscopy measurements (Raman, diffuse reflectance and laser induced fluorescence spectroscopy) from skin lesion sites. In order to accomplish this objective, the investigators propose to: 1) develop biophysical model for Raman spectroscopy of skin cancers, 2) conduct a clinical pilot study to collect MMS data from a minimum of 250 patients to determine the diagnostic accuracy (sensitivity and specificity) of MMS for diagnosing skin malignancy.

Key facts

Study ID

NCT02704039

Run by

University of Texas at Austin

People needed

239

Starts

2016-01-01

Expected to finish

2018-12-01

Last updated by the study team

2019-03-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients undergoing examination of skin
• Male or Female 18 years and older
• Patients with lesion(s) including one of the following: BCC, SCC, pre-cancerous, pigmented lesion, benign lesions, OR suspected diagnosis of psoriasis, eczema, dermatitis, lichen planus and/or lupus.
• Signed consent form

You may not qualify if…

• Patients with skin lesions in difficult to measure locations
• Patients that do not sign the consent forms

Where it is running

• Seton Dermatology Clinics — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.